CVE-2011-0430

Description

Double free vulnerability in the Rx server process in OpenAFS 1.4.14, 1.4.12, 1.4.7, and possibly other versions allows remote attackers to cause a denial of service and execute arbitrary code via unknown vectors.

Category

7.5
CVSS
Severity: High
CVSS 2.0 •
EPSS 2.29% Top 20%
Vendor Advisory debian.org Vendor Advisory secunia.com Vendor Advisory secunia.com Vendor Advisory vupen.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/46428 vdb entry
http://www.debian.org/security/2011/dsa-2168 vendor advisory
http://www.vupen.com/english/advisories/2011/0410 vdb entry vendor advisory
http://secunia.com/advisories/43371 third party advisory vendor advisory
http://www.securitytracker.com/id?1025095 vdb entry
http://www.vupen.com/english/advisories/2011/0411 vdb entry vendor advisory
http://secunia.com/advisories/43407 third party advisory vendor advisory

Frequently Asked Questions

What is the severity of CVE-2011-0430?
CVE-2011-0430 has been scored as a high severity vulnerability.
How to fix CVE-2011-0430?
To fix CVE-2011-0430, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2011-0430 being actively exploited in the wild?
It is possible that CVE-2011-0430 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.